Literature DB >> 23334670

Adjuvant methods to improve results of local bladder irrigations by chemotherapy for NMIBC.

Yuval Freifeld1, Yoram Dekel, Avi Stein.   

Abstract

Non-muscle-invasive bladder cancer is characterized by frequent recurrences requiring repeated transurethral resections and carries a risk of progression to muscle-invasive disease. The routinely used, passive diffusion irrigation of the bladder with mitomycin C has achieved limited success in avoiding these events. We review two methods that may improve penetration of mitomycin C into the bladder wall, thus leading to better results in terms of recurrence rate and bladder preservation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23334670     DOI: 10.1007/s11934-012-0302-9

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   3.092


  42 in total

1.  [EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update].

Authors:  M Babjuk; W Oosterlinck; R Sylvester; E Kaasinen; A Böhle; J Palou-Redorta; M Rouprêt
Journal:  Actas Urol Esp       Date:  2012-03-02       Impact factor: 0.994

2.  Methods to improve efficacy of intravesical mitomycin C: results of a randomized phase III trial.

Authors:  J L Au; R A Badalament; M G Wientjes; D C Young; J A Warner; P L Venema; D L Pollifrone; J D Harbrecht; J L Chin; S P Lerner; B J Miles
Journal:  J Natl Cancer Inst       Date:  2001-04-18       Impact factor: 13.506

3.  Plasma mitomycin C concentrations determined by HPLC coupled to solid-phase extraction.

Authors:  R Paroni; C Arcelloni; E De Vecchi; I Fermo; D Mauri; R Colombo
Journal:  Clin Chem       Date:  1997-04       Impact factor: 8.327

Review 4.  Rationale for intravesical chemotherapy in the treatment and prophylaxis of superficial transitional cell carcinoma.

Authors:  M S Soloway; A M Jordan; W M Murphy
Journal:  Prog Clin Biol Res       Date:  1989

Review 5.  The role of a combined regimen with intravesical chemotherapy and hyperthermia in the management of non-muscle-invasive bladder cancer: a systematic review.

Authors:  Rianne J M Lammers; J Alfred Witjes; Brant A Inman; Ilan Leibovitch; Menachem Laufer; Ofer Nativ; Renzo Colombo
Journal:  Eur Urol       Date:  2011-04-20       Impact factor: 20.096

6.  Electromotive drug administration to the urinary bladder: an animal model and preliminary results.

Authors:  T Gürpinar; L D Truong; H Y Wong; D P Griffith
Journal:  J Urol       Date:  1996-10       Impact factor: 7.450

7.  An individual patient data meta-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin C versus bacillus Calmette-Guérin for non-muscle-invasive bladder cancer.

Authors:  Per-Uno Malmström; Richard J Sylvester; David E Crawford; Martin Friedrich; Susanne Krege; Erkki Rintala; Eduardo Solsona; Savino M Di Stasi; J Alfred Witjes
Journal:  Eur Urol       Date:  2009-04-24       Impact factor: 20.096

8.  Bladder wall penetration of intravesical mitomycin C in dogs.

Authors:  M G Wientjes; J T Dalton; R A Badalament; J R Drago; J L Au
Journal:  Cancer Res       Date:  1991-08-15       Impact factor: 12.701

9.  Preliminary European results of local microwave hyperthermia and chemotherapy treatment in intermediate or high risk superficial transitional cell carcinoma of the bladder.

Authors:  A G van der Heijden; L A Kiemeney; O N Gofrit; O Nativ; A Sidi; Z Leib; R Colombo; R Naspro; M Pavone; J Baniel; F Hasner; J A Witjes
Journal:  Eur Urol       Date:  2004-07       Impact factor: 20.096

10.  Long-term outcomes of a randomized controlled trial comparing thermochemotherapy with mitomycin-C alone as adjuvant treatment for non-muscle-invasive bladder cancer (NMIBC).

Authors:  Renzo Colombo; Andrea Salonia; Zvi Leib; Michele Pavone-Macaluso; Dov Engelstein
Journal:  BJU Int       Date:  2010-10-04       Impact factor: 5.588

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.